Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905148-25-004067
Filing Date
2025-11-14
Accepted
2025-11-14 16:57:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5646
2 subsidiaries.htm EX-99.1 2991
  Complete submission text file 0000905148-25-004067.txt   10774
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Subject) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1227
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-59553 | Film No.: 251487828
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1-13-1 NIHONBASHI CHUO-KU TOKYO Japan 103-8645
Business Address 1-13-1 NIHONBASHI CHUO-KU TOKYO Japan 103-8645 81-3-5255-1000
NOMURA HOLDINGS INC (Filed by) CIK: 0001163653 (see all company filings)

EIN.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)